Although it has been proposed as a therapeutic intervention to mitigate hyperinflammatory CL, earlier reports suggesting a direct correlation between NLRP3 subversion and MCL severity present conflicting results [84]. The gene discussed is NLRP3; the disease is mantle cell lymphoma.